Sequential Combination of Chemotherapy With Gemcitabine/Oxaliplatin and Photodynamic Therapy in Advanced Cholangiocarcinoma
Patients entered in the study receive a sequential therapy consisted of photodynamic therapy
followed by systemic chemotherapy (Gemcitabine/Oxaliplatin) 4 weeks later. Systemic
chemotherapy every 2 weeks is scheduled 9 times in each cycle. Thereafter, another cycle of
PDT followed by chemotherapy is intended.
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Progression free survival 6 months after study start
6 months after study start
Matthias Ebert, Prof. Dr.
Head of the gastroenterological department of the Klinikum rechts der Isar
Germany: Ethics Commission